Wechselwirkungen · SomaKit TOC
SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation · Abschnitt 4.5 · PDF-Seite 5
HOS-135631 · Präparat HOS-097746
Somatostatin and its analogues are probably competing to bind to the same somatostatin receptors. Therefore, when treating patients with somatostatin analogues, it is preferable to perform imaging with gallium (68Ga) edotreotide the day(s) preceding the next administration of a somatostatin analogue. A long-term exposure to endogenous hypercortisolism may down-regulate somatostatin receptor expression and negatively influence the results of somatostatin receptor imaging with gallium (68Ga) edotreotide. In patients with Cushing syndrome, the normalisation of hypercortisolism should be considered before performing PET with SomaKit TOC.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): gallium (HOS-135632) somatostatin (HOS-110277)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-28T14:43:00Z · SHA-256 0bfef9343096358c965949fb7b95caa13ec3e2fd1450bafb586a9349044b073d · Passage 5f403d1eb55922e023332b23b80b503d3b27a8e53d12c9c1f1c8956293a1883c · Zeichen 0–641 im Abschnitt